| ASSET | DECADE | % RETURN |
|---|---|---|
Cato (CATO) | 1990s | 1,834.15% |
Envela (ELA) | 1990s | 985.47% |
BioLife Solutions (BLFS) | 1990s | 765.98% |
Biomerica (BMRA) | 1990s | 652.87% |
Magna International (MGA) | 1990s | 610.49% |
Shyft (SHYF) | 1990s | 591.56% |
Jack Henry & Associates (JKHY) | 1990s | 572.99% |
International Game Technology (IGT) | 1990s | 441.24% |
Abeona Therapeutics (ABEO) | 1990s | 433.51% |
Oppenheimer (OPY) | 1990s | 418.2% |
Gencor Industries (GENC) | 1990s | 411.21% |
Vicor (VICR) | 1990s | 398.56% |
Heron Therapeuti (HRTX) | 1990s | 394.12% |
Mesa Laboratories (MLAB) | 1990s | 383.34% |
CEL-SCI (CVM) | 1990s | 379.07% |
National HealthCare (NHC) | 1990s | 335.92% |
Veru (VERU) | 1990s | 325.4% |
Toll Brothers (TOL) | 1990s | 309.1% |
STAAR Surgical (STAA) | 1990s | 306.95% |
Bio-Techne (TECH) | 1990s | 303.96% |
Electronic Arts (EA) | 1990s | 302.66% |
Educational Development (EDUC) | 1990s | 299.7% |
Charles Schwab (SCHW) | 1990s | 295.22% |
Plexus (PLXS) | 1990s | 289.75% |
Celldex Therapeutics (CLDX) | 1990s | 282.61% |
